Dupuytren's disease can cause severe joint contracture in the hands, and surgery is often recommended for these patients most affected by the condition. But Dr. Lawrence Hurst, professor, chairman and chief of the division of hand surgery in the department of orthopaedics at Stony Brook School of Medicine Health Sciences Center, tells us about another new, non-surgical option that may soon be available for treating Dupuytren's contracture, using injectable collagenase. What types of patients are most susceptible to developing this condition? Dr. Lee Freedman hosts.
